Histone H4 acetylation is dysregulated in active seminiferous tubules adjacent to testicular tumours

Study question: Is histone H4 acetylation (H4ac) altered in the seminiferous tubules of patients affected by testicular tumours? Summary answer: A considerable dysregulation of H4ac was detected in the cells of the seminiferous tubules adjacent to testicular tumours of different aetiology and prior...

Descripción completa

Detalles Bibliográficos
Autores: Ballescà, Josep Lluís, Barrachina Villalonga, Ferran, Iglesia Rodriguez, Alberto de la, Jodar Bifet, Meritxell, Soler Ventura, Ada, Mallofré i Gómez, Carme, Rodríguez-Carunchio, Leonardo, Goudarzi, Afsaneh, Corral, Juan Manuel, Castillo Corullón, Judit, Oliva Virgili, Rafael
Tipo de recurso: artículo
Estado:Versión aceptada para publicación
Fecha de publicación:2022
País:España
Institución:Universidad de Barcelona
Repositorio:Dipòsit Digital de la UB
OAI Identifier:oai:diposit.ub.edu:2445/218066
Acceso en línea:https://hdl.handle.net/2445/218066
Access Level:acceso abierto
Palabra clave:Epigenètica
Espermatogènesi
Tumors
Immunohistoquímica
Epigenetics
Spermatogenesis
Immunohistochemistry
id ES_b9e7e1fecb0745f3d29c4e0a7694f3a8
oai_identifier_str oai:diposit.ub.edu:2445/218066
network_acronym_str ES
network_name_str España
repository_id_str
dc.title.none.fl_str_mv Histone H4 acetylation is dysregulated in active seminiferous tubules adjacent to testicular tumours
title Histone H4 acetylation is dysregulated in active seminiferous tubules adjacent to testicular tumours
spellingShingle Histone H4 acetylation is dysregulated in active seminiferous tubules adjacent to testicular tumours
Ballescà, Josep Lluís
Epigenètica
Espermatogènesi
Tumors
Immunohistoquímica
Epigenetics
Spermatogenesis
Tumors
Immunohistochemistry
title_short Histone H4 acetylation is dysregulated in active seminiferous tubules adjacent to testicular tumours
title_full Histone H4 acetylation is dysregulated in active seminiferous tubules adjacent to testicular tumours
title_fullStr Histone H4 acetylation is dysregulated in active seminiferous tubules adjacent to testicular tumours
title_full_unstemmed Histone H4 acetylation is dysregulated in active seminiferous tubules adjacent to testicular tumours
title_sort Histone H4 acetylation is dysregulated in active seminiferous tubules adjacent to testicular tumours
dc.creator.none.fl_str_mv Ballescà, Josep Lluís
Barrachina Villalonga, Ferran
Iglesia Rodriguez, Alberto de la
Jodar Bifet, Meritxell
Soler Ventura, Ada
Mallofré i Gómez, Carme
Rodríguez-Carunchio, Leonardo
Goudarzi, Afsaneh
Corral, Juan Manuel
Castillo Corullón, Judit
Oliva Virgili, Rafael
author Ballescà, Josep Lluís
author_facet Ballescà, Josep Lluís
Barrachina Villalonga, Ferran
Iglesia Rodriguez, Alberto de la
Jodar Bifet, Meritxell
Soler Ventura, Ada
Mallofré i Gómez, Carme
Rodríguez-Carunchio, Leonardo
Goudarzi, Afsaneh
Corral, Juan Manuel
Castillo Corullón, Judit
Oliva Virgili, Rafael
author_role author
author2 Barrachina Villalonga, Ferran
Iglesia Rodriguez, Alberto de la
Jodar Bifet, Meritxell
Soler Ventura, Ada
Mallofré i Gómez, Carme
Rodríguez-Carunchio, Leonardo
Goudarzi, Afsaneh
Corral, Juan Manuel
Castillo Corullón, Judit
Oliva Virgili, Rafael
author2_role author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Epigenètica
Espermatogènesi
Tumors
Immunohistoquímica
Epigenetics
Spermatogenesis
Tumors
Immunohistochemistry
topic Epigenètica
Espermatogènesi
Tumors
Immunohistoquímica
Epigenetics
Spermatogenesis
Tumors
Immunohistochemistry
description Study question: Is histone H4 acetylation (H4ac) altered in the seminiferous tubules of patients affected by testicular tumours? Summary answer: A considerable dysregulation of H4ac was detected in the cells of the seminiferous tubules adjacent to testicular tumours of different aetiology and prior to any treatment, while no comparable alterations were observed in patients with disrupted spermatogenesis. What is known already: Altered H4ac levels have been associated with a variety of testicular pathological conditions. However, no information has been available regarding potential alterations in the spermatogenic cells adjacent to the neoplasia in testicular tumour patients. Study design, size, duration: A retrospective analysis using testicular sections from 33 men aged between 21 and 74 years old was performed. Three study groups were defined and subjected to double-blind evaluation: a control group with normal spermatogenesis (n = 6), patients with testicular tumours (n = 18) and patients with spermatogenic impairments (n = 8). One additional sample with normal spermatogenesis was used as a technical internal control in all evaluations. Participants/materials, setting, methods: Immunohistochemistry against H4ac and, when needed, Placental-like alkaline phosphatase and CD117, was performed on testicular sections. The H4ac H-score, based on the percentage of detection and signal intensity, was used as the scoring method for statistical analyses. Protein expression data from the Human Protein Atlas were used to compare the expression levels of predicted secreted proteins from testicular tumours with those present in the normal tissue. Main results and the role of chance: We revealed, for the first time, a dramatic disruption of the spermatogenic H4ac pattern in unaffected seminiferous tubule cells from different testicular tumour patients prior to any antineoplastic treatment, as compared to controls (P < 0.05). Since no similar alterations were associated with spermatogenic impairments and the in silico analysis revealed proteins potentially secreted by the tumour to the testicular stroma, we propose a potential paracrine effect of the neoplasia as a mechanistic hypothesis for this dysregulation. Limitations, reasons for caution: Statistical analyses were not performed on the hypospermatogenesis and Leydig cell tumour groups due to limited availability of samples. Wider implications of the findings: To the best of our knowledge, this is the first report showing an epigenetic alteration in cells from active seminiferous tubules adjacent to tumour cells in testicular tumour patients. Our results suggest that, despite presenting spermatogenic activity, the global epigenetic dysregulation found in the testicular tumour patients could lead to molecular alterations of the male germ cells. Since testicular tumours are normally diagnosed in men at reproductive age, H4ac alterations might have an impact when these testicular tumour patients express a desire for fatherhood. Study funding/competing interest(s): This work was supported by the European Union Marie Curie European Training Network actions and by grants to R.O. from the 'Ministerio de Economía y Competividad (Spain)' (fondos FEDER 'una manera de hacer Europa', PI13/00699, PI16/00346 and PI20/00936) and from EU-FP7-PEOPLE-2011-ITN289880. J.C. was supported by the Sara Borrell Postdoctoral Fellowship, Acción Estratégica en Salud, CD17/00109. J.C. is a Serra Húnter fellow (Universitat de Barcelona, Generalitat de Catalunya). F.B. has received grants from the Ministerio de Educación, Cultura y Deporte para la Formación de Profesorado Universitario (Spain) (FPU15/02306). A.d.l.I. is supported by a fellowship of the Ministerio de Economía, Industria y Competitividad (Spain) (PFIS, FI17/00224). M.J. is supported by the Government of Catalonia (Generalitat de Catalunya, pla estratègic de recerca i innovació en salut, PERIS 2016-2020, SLT002/16/00337). The authors have no conflicts of interest to declare.
publishDate 2022
dc.date.none.fl_str_mv 2022
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/acceptedVersion
format article
status_str acceptedVersion
dc.identifier.none.fl_str_mv https://hdl.handle.net/2445/218066
url https://hdl.handle.net/2445/218066
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.relation.none.fl_str_mv Versió postprint del document publicat a: https://doi.org/10.1093/humrep/deac130
Human Reproduction, 2022, vol. 37, num.8, p. 1712-1726
https://doi.org/10.1093/humrep/deac130
dc.rights.none.fl_str_mv (c) Barrachina F et al., 2022
info:eu-repo/semantics/openAccess
rights_invalid_str_mv (c) Barrachina F et al., 2022
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv European Society of Human Reproduction and Embryology
publisher.none.fl_str_mv European Society of Human Reproduction and Embryology
dc.source.none.fl_str_mv Articles publicats en revistes (Biomedicina)
reponame:Dipòsit Digital de la UB
instname:Universidad de Barcelona
instname_str Universidad de Barcelona
reponame_str Dipòsit Digital de la UB
collection Dipòsit Digital de la UB
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869417812785627137
spelling Histone H4 acetylation is dysregulated in active seminiferous tubules adjacent to testicular tumoursBallescà, Josep LluísBarrachina Villalonga, FerranIglesia Rodriguez, Alberto de laJodar Bifet, MeritxellSoler Ventura, AdaMallofré i Gómez, CarmeRodríguez-Carunchio, LeonardoGoudarzi, AfsanehCorral, Juan ManuelCastillo Corullón, JuditOliva Virgili, RafaelEpigenèticaEspermatogènesiTumorsImmunohistoquímicaEpigeneticsSpermatogenesisTumorsImmunohistochemistryStudy question: Is histone H4 acetylation (H4ac) altered in the seminiferous tubules of patients affected by testicular tumours? Summary answer: A considerable dysregulation of H4ac was detected in the cells of the seminiferous tubules adjacent to testicular tumours of different aetiology and prior to any treatment, while no comparable alterations were observed in patients with disrupted spermatogenesis. What is known already: Altered H4ac levels have been associated with a variety of testicular pathological conditions. However, no information has been available regarding potential alterations in the spermatogenic cells adjacent to the neoplasia in testicular tumour patients. Study design, size, duration: A retrospective analysis using testicular sections from 33 men aged between 21 and 74 years old was performed. Three study groups were defined and subjected to double-blind evaluation: a control group with normal spermatogenesis (n = 6), patients with testicular tumours (n = 18) and patients with spermatogenic impairments (n = 8). One additional sample with normal spermatogenesis was used as a technical internal control in all evaluations. Participants/materials, setting, methods: Immunohistochemistry against H4ac and, when needed, Placental-like alkaline phosphatase and CD117, was performed on testicular sections. The H4ac H-score, based on the percentage of detection and signal intensity, was used as the scoring method for statistical analyses. Protein expression data from the Human Protein Atlas were used to compare the expression levels of predicted secreted proteins from testicular tumours with those present in the normal tissue. Main results and the role of chance: We revealed, for the first time, a dramatic disruption of the spermatogenic H4ac pattern in unaffected seminiferous tubule cells from different testicular tumour patients prior to any antineoplastic treatment, as compared to controls (P < 0.05). Since no similar alterations were associated with spermatogenic impairments and the in silico analysis revealed proteins potentially secreted by the tumour to the testicular stroma, we propose a potential paracrine effect of the neoplasia as a mechanistic hypothesis for this dysregulation. Limitations, reasons for caution: Statistical analyses were not performed on the hypospermatogenesis and Leydig cell tumour groups due to limited availability of samples. Wider implications of the findings: To the best of our knowledge, this is the first report showing an epigenetic alteration in cells from active seminiferous tubules adjacent to tumour cells in testicular tumour patients. Our results suggest that, despite presenting spermatogenic activity, the global epigenetic dysregulation found in the testicular tumour patients could lead to molecular alterations of the male germ cells. Since testicular tumours are normally diagnosed in men at reproductive age, H4ac alterations might have an impact when these testicular tumour patients express a desire for fatherhood. Study funding/competing interest(s): This work was supported by the European Union Marie Curie European Training Network actions and by grants to R.O. from the 'Ministerio de Economía y Competividad (Spain)' (fondos FEDER 'una manera de hacer Europa', PI13/00699, PI16/00346 and PI20/00936) and from EU-FP7-PEOPLE-2011-ITN289880. J.C. was supported by the Sara Borrell Postdoctoral Fellowship, Acción Estratégica en Salud, CD17/00109. J.C. is a Serra Húnter fellow (Universitat de Barcelona, Generalitat de Catalunya). F.B. has received grants from the Ministerio de Educación, Cultura y Deporte para la Formación de Profesorado Universitario (Spain) (FPU15/02306). A.d.l.I. is supported by a fellowship of the Ministerio de Economía, Industria y Competitividad (Spain) (PFIS, FI17/00224). M.J. is supported by the Government of Catalonia (Generalitat de Catalunya, pla estratègic de recerca i innovació en salut, PERIS 2016-2020, SLT002/16/00337). The authors have no conflicts of interest to declare.European Society of Human Reproduction and Embryology2022info:eu-repo/semantics/articleinfo:eu-repo/semantics/acceptedVersionapplication/pdfhttps://hdl.handle.net/2445/218066Articles publicats en revistes (Biomedicina)reponame:Dipòsit Digital de la UBinstname:Universidad de BarcelonaInglésVersió postprint del document publicat a: https://doi.org/10.1093/humrep/deac130Human Reproduction, 2022, vol. 37, num.8, p. 1712-1726https://doi.org/10.1093/humrep/deac130(c) Barrachina F et al., 2022info:eu-repo/semantics/openAccessoai:diposit.ub.edu:2445/2180662026-05-27T06:46:51Z
score 15,812455